Of mice, men, and NLGN4 (2019)

First Author: Osterweil E
Attributed to:  Targeting ERK and mTOR for the treatment of fragile X syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aaz0307

Publication URI: http://dx.doi.org/10.1126/scitranslmed.aaz0307

Type: Journal Article/Review

Parent Publication: Science Translational Medicine

Issue: 508